Stock Taper 
ROCK SPRINGS CAPITAL MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Glaukos Corporation | GKOS | 4.75K | $663.86K |
 Axsome Therapeutics, Inc. | AXSM | 5.5K | $1.35M |
 Thermo Fisher Scientific Inc. | TMO | 10K | $5.01M |
 MoonLake Immunotherapeutics | MLTX | 10.7K | $208.25K |
 Oruka Therapeutics, Inc. | ORKA | 12.05K | $1.15M |
 Dianthus Therapeutics, Inc. | DNTH | 20.33K | $1.98M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 22.12K | $221.24K |
 Viking Therapeutics, Inc. | VKTX | 25.5K | $994.75K |
 Stryker Corporation | SYK | 29K | $9.13M |
 Medtronic plc | MDT | 30.9K | $2.42M |
 Legend Biotech Corporation | LEGN | 33.5K | $967.48K |
 CVS Health Corp. | CVS | 40K | $4.14M |
 Spyre Therapeutics, Inc. | SYRE | 42.25K | $3.75M |
 argenx SE | ARGX | 52.75K | $48.94M |
 Teva Pharmaceutical Industries Limited | TEVA | 59K | $2M |
 Vaxcyte, Inc. | PCVX | 60.25K | $3.5M |
 Novo Nordisk A/S | NVO | 63.5K | $3.04M |
 UnitedHealth Group Incorporated | UNH | 63.75K | $26.5M |
 Kailera Therapeutics, Inc. | KLRA | 65K | $1.43M |
 Alnylam Pharmaceuticals, Inc. | ALNY | 66.75K | $20.09M |